Malaria

Latest

Mosquito Biologist Dr. Bart Knols, points to an Anopheles mosquito larvae as he speaks on the use of drone technology in the fight against malaria, in a rice field near Zanzibar City, on the island of Zanzibar, Tanzania, October 30, 2019. Picture taken October 30, 2019. REUTERS/Baz Ratner

As Malaria Spreads, Africa Needs Data on Gene-Edited Mosquitos

by

Gene drives could be transformational for the malaria response, but countries need evidence to weigh the benefits over the risks

A forklift unloads boxes containing vials of the R21 malaria vaccine inside a cold room at the Serum Institute of India, in Pune, India, on February 27, 2024.

Making Aid Transition Work: Seven Lessons From the Private Sector

by , ,

As global health financing shifts toward country self-reliance, emphasis on principles like measurement and accountability can guide implementation

Why U.S.-Zambia Foreign Aid Negotiations Should Continue

by

International Vaccine Access Center lead William Moss explains why Zambia needs funding to maintain progress on malaria, HIV, and vaccination programs

A home-based caregiver visits an HIV/AIDS patient in her home in Matero township, Lusaka, Zambia, on April 17, 2012.

Securing Sustainable Funding for Civil Society Organizations

by , ,

The United States and Global Fund should work with partner governments to transition support for groups delivering HIV and tuberculosis services after aid cuts

HIV-positive members of a self-help group meet with a caregiver in the village of Michelo, Zambia, on February 23, 2015.

What the Development Finance Corporation Reauthorization Means for Global Health Security

by , , , ,

The federal institution's new authorities and expanded mandate could facilitate U.S. engagement on global health security

Researchers work inside a laboratory at the International Centre of Insect Physiology and Ecology (ICIPE) headquarters, in Nairobi, Kenya, on May 11, 2020.

The United States Maintains Its Global Fund Commitment

by ,

The $4.6 billion pledge shows the willingness of the United States to support multilateral agencies that meet certain criteria

Norway's Prime Minister Jonas Gahr Store listens during the Global Fund event on November 21, 2025, in Sandton, Johannesburg, South Africa, ahead of the G20 Summit, which begins tomorrow. Leon Neal/Pool via REUTERS

The New America First Global Health Strategy: Four Observations

by , , ,

What the strategy means for supply chain reforms, transnational threats, and congressional oversight on global health spending

U.S. President Donald Trump delivers an address to the nation alongside U.S. Vice President JD Vance, U.S. Secretary of State Marco Rubio and U.S. Defense Secretary Pete Hegseth, in Washington DC, on June 21, 2025.

A New Malaria Drug Can Treat Infants—If Health Systems Support It

by ,

In July, Coartem Baby became the first approved malaria treatment for newborns and infants

Map of Africa shaded to show malaria mortality rates among children under 5, measured per 100,000 people in 2021. Darker red indicates higher mortality, with rates up to 500. The highest rates appear across West and Central Africa, with Burkina Faso marked as having the highest rate. Countries in northern and southern Africa are shaded light gray, indicating very low or no reported mortality. A legend in the top right shows the gradient from 0 (light gray) to 500 (dark red).

Indonesia's Move to Eliminate Malaria

by

By joining the WHO's Western Pacific Region, Indonesia can strengthen alliances to eliminate mosquito-borne illnesses

Indonesia's Move to Eliminate Malaria

Preserving Refugee Health in Uganda

by

Amid U.S. funding cuts, Uganda works to protect its rapidly growing refugee population from deadly diseases

Preserving Refugee Health in Uganda

Eliminating Malaria in ASEAN: Lessons From Egypt

by ,

Strategies like environmental management and cross-border collaboration would control malaria spread in ASEAN countries

Eliminating Malaria in ASEAN: Lessons From Egypt

Mapping Supply Chains: Global Health Agencies Lead the Way

by

Global health agencies can teach valuable lessons about drug supply risks and upstream supply chains

Mapping Supply Chains: Global Health Agencies Lead the Way